Agilent Technologies Gross Profit 2010-2025 | A

Agilent Technologies annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Agilent Technologies gross profit for the quarter ending April 30, 2025 was $866M, a 1.17% increase year-over-year.
  • Agilent Technologies gross profit for the twelve months ending April 30, 2025 was $3.536B, a 5.96% increase year-over-year.
  • Agilent Technologies annual gross profit for 2024 was $3.535B, a 2.02% increase from 2023.
  • Agilent Technologies annual gross profit for 2023 was $3.465B, a 6.9% decline from 2022.
  • Agilent Technologies annual gross profit for 2022 was $3.722B, a 9.25% increase from 2021.
Agilent Technologies Annual Gross Profit
(Millions of US $)
2024 $3,535
2023 $3,465
2022 $3,722
2021 $3,407
2020 $2,837
2019 $2,805
2018 $2,680
2017 $2,399
2016 $2,197
2015 $2,041
2014 $1,976
2013 $1,907
2012 $3,604
2011 $3,529
2010 $2,930
2009 $2,292
Agilent Technologies Quarterly Gross Profit
(Millions of US $)
2025-04-30 $866
2025-01-31 $899
2024-10-31 $916
2024-07-31 $855
2024-04-30 $856
2024-01-31 $908
2023-10-31 $915
2023-07-31 $658
2023-04-30 $924
2023-01-31 $968
2022-10-31 $1,012
2022-07-31 $939
2022-04-30 $861
2022-01-31 $910
2021-10-31 $900
2021-07-31 $852
2021-04-30 $817
2021-01-31 $838
2020-10-31 $788
2020-07-31 $669
2020-04-30 $657
2020-01-31 $723
2019-10-31 $737
2019-07-31 $692
2019-04-30 $669
2019-01-31 $707
2018-10-31 $708
2018-07-31 $659
2018-04-30 $643
2018-01-31 $670
2017-10-31 $637
2017-07-31 $596
2017-04-30 $592
2017-01-31 $574
2016-10-31 $588
2016-07-31 $542
2016-04-30 $530
2016-01-31 $537
2015-10-31 $535
2015-07-31 $513
2015-04-30 $480
2015-01-31 $513
2014-10-31 $897
2014-07-31 $502
2014-04-30 $485
2014-01-31 $510
2013-10-31 $908
2013-07-31 $856
2013-04-30 $891
2013-01-31 $880
2012-10-31 $922
2012-07-31 $890
2012-04-30 $918
2012-01-31 $874
2011-10-31 $921
2011-07-31 $892
2011-04-30 $900
2011-01-31 $816
2010-10-31 $834
2010-07-31 $725
2010-04-30 $711
2010-01-31 $660
2009-10-31 $634
2009-07-31 $539
2009-04-30 $530
2009-01-31 $589
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $35.020B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.693B 27.62
Boston Scientific (BSX) United States $152.679B 38.22
Stryker (SYK) United States $148.653B 31.08
EssilorLuxottica (ESLOY) France $131.422B 0.00
Medtronic (MDT) Ireland $115.326B 16.35
Lonza Group Ag (LZAGY) Switzerland $51.078B 0.00
Haleon (HLN) United Kingdom $44.743B 25.54
ResMed (RMD) United States $37.302B 28.02
GE HealthCare Technologies (GEHC) United States $34.401B 16.33
Terumo (TRUMY) Japan $24.607B 31.96
Koninklijke Philips (PHG) Netherlands $23.139B 16.24
Insulet (PODD) United States $20.361B 79.92
Zimmer Biomet Holdings (ZBH) United States $18.556B 11.92
Baxter (BAX) United States $14.728B 11.00
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.993B 24.33
Lantheus Holdings (LNTH) United States $5.626B 14.19
Perrigo (PRGO) Ireland $3.785B 9.59
Prestige Consumer Healthcare (PBH) United States $3.780B 16.89
Haemonetics (HAE) United States $3.628B 16.53
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.424B 28.45
ICU Medical (ICUI) United States $3.253B 23.99
QuidelOrtho (QDEL) United States $2.052B 14.11
LeMaitre Vascular (LMAT) United States $1.891B 42.27
AtriCure (ATRC) United States $1.521B 0.00
Acuren (TIC) United States $1.395B 0.00
Green Thumb Industries (GTBIF) United States $1.389B 31.24
Phibro Animal Health (PAHC) United States $1.248B 15.96
AdaptHealth (AHCO) United States $1.244B 12.63
Neogen (NEOG) United States $1.170B 14.97
BioLife Solutions (BLFS) United States $1.050B 0.00
InMode (INMD) Israel $0.930B 9.37
Curaleaf Holdings (CURLF) Canada $0.771B 0.00
Kestra Medical Technologies (KMTS) United States $0.766B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.695B 0.00
Owens & Minor (OMI) United States $0.627B 5.21
Evolus (EOLS) United States $0.611B 0.00
Tilray Brands (TLRY) Canada $0.584B 0.00
CeriBell (CBLL) United States $0.583B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.365B 0.00
Capricor Therapeutics (CAPR) United States $0.349B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.38
Cresco Labs (CRLBF) United States $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.298B 0.00
Quanterix (QTRX) United States $0.294B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Sanara MedTech (SMTI) United States $0.258B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.83
ZimVie (ZIMV) United States $0.251B 11.39
Verano Holdings (VRNOF) United States $0.235B 0.00
Brainsway (BWAY) Israel $0.233B 61.55
OraSure Technologies (OSUR) United States $0.232B 0.00
Biote (BTMD) United States $0.223B 6.28
Omeros (OMER) United States $0.214B 0.00
Canopy Growth (CGC) Canada $0.208B 0.00
Organigram Global (OGI) Canada $0.194B 0.00
High Tide (HITI) Canada $0.191B 0.00
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.93
Vireo Growth (VREOF) United States $0.163B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.122B 15.05
TerrAscend (TSNDF) Canada $0.117B 0.00
MacroGenics (MGNX) United States $0.102B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.68
Jushi Holdings (JUSHF) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.074B 0.00
Zynex (ZYXI) United States $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.039B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Nephros (NEPH) United States $0.038B 51.43
United-Guardian (UG) United States $0.037B 12.89
Safety Shot (SHOT) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00